CVS Health (CVS) Receives a Buy from Barclays
Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $73.00. The ...
Top Analysts Upgrade CVS Health Stock (CVS) after Upbeat Q4 Results
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...